In a notable development in India’s healthcare and energy sectors, the Competition Commission of India (CCI) has granted approval for Fortis Healthcare to raise its stake in Agilus Diagnostics by an additional 31.52%, boosting its ownership from 57.68% to a commanding 89.2%. The acquisition, valued at ₹1,780 crore, places Agilus Diagnostics’ overall valuation at approximately ₹5,700 crore.

With this strategic move, Fortis Healthcare strengthens its integrated healthcare model, further embedding diagnostics as a critical component of its service portfolio. As Agilus becomes a more prominent arm of Fortis’s diagnostics capabilities, the healthcare provider aims to leverage operational synergies to enhance service delivery and broaden its diagnostics reach across India.

In a statement on social media, CCI confirmed, “Commission approves the acquisition of additional 31.52 per cent share capital of Agilus Diagnostics by Fortis Healthcare.” Fortis, one of India’s leading multi-specialty hospital networks, has actively expanded its diagnostics segment to complement its core hospital services. This stake hike signals a continued focus on expanding diagnostic services to provide comprehensive, integrated healthcare solutions to its patients.

In a separate decision, CCI also approved the merger of Diliigent Power with DB Power, along with a reorganization involving Decore Thermal Power as part of a share buyback plan. Diliigent Power, which operates through its wholly-owned subsidiary DB Power, specializes in power generation and offers project management services, while Decore Thermal Power serves as the holding entity for DB Power’s assets in Singrauli District, Madhya Pradesh. The merger and restructuring efforts aim to streamline operations and strengthen DB Power’s position in the power generation and project management sectors.

Also Read: Government Spends ₹1.1 Lakh Crore on Free Hospitalization Under PM-JAY, Benefiting Millions of Indian Households.

According to CCI regulations, mergers and acquisitions surpassing certain financial thresholds require regulatory review to ensure fair competition and prevent monopolistic practices. These recent approvals reinforce CCI’s commitment to fostering a balanced competitive landscape while supporting corporate restructuring efforts.

These approvals underscore ongoing consolidation in India’s healthcare and power sectors, with Fortis Healthcare and Diliigent Power positioning themselves to reinforce their market presence through strategic acquisitions and streamlined operational structures.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!